background splenic irradiation si fairly unknown treatment modality autoimmune disorders like autoimmune thrombocytopenia ait autoimmune hemolytic anemia aiha provide effective low toxic treatment selected patients patients materials methods article reviews limited experiences splenic irradiation autoimmune thrombocytopenia analyzing current studies including NUMBER patients preliminary reports splenic irradiation autoimmune hemolytic anemia results autoimmune thrombocytopenia NUMBER NUMBER patients responded relapsed NUMBER NUMBER months splenic irradiation NUMBER NUMBER patients sustained response efficacy splenic irradiation cases thrombocytopenia probably lower forms autoimmune thrombocytopenia especially group immunosuppressive drug treatment autoimmune thrombocytopenia exposes problems autoimmune hemolytic anemia case reports efficacy splenic irradiation toxicity splenic irradiation diseases moderate conclusions hiv patients elderly patients patients high risk complications following splenectomy splenic irradiation treatment option splenic irradiation preoperative treatment patients responding suitable immunosuppressive drugs prior splenectomy promising new application splenic irradiation reduce adverse effects splenectomy thrombocytopenic patients analysis biological mechanisms underlying splenic irradiation help improve patient selection optimize dose concepts treatment schedules improve understanding radiotherapy immunomodulatory treatment modality references NUMBER cost effective hiv associated